Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2021-06 Issue:10290 Volume:397 Page:2169-2181
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Reich Kristian,Teixeira Henrique D,de Bruin-Weller Marjolein,Bieber Thomas,Soong Weily,Kabashima Kenji,Werfel Thomas,Zeng Jiewei,Huang Xiaohong,Hu Xiaofei,Hendrickson Barbara A,Ladizinski Barry,Chu Alvina D,Silverberg Jonathan I

Funder

Sanofi

AbbVie

Pfizer

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions;Hay;J Invest Dermatol,2014

2. Atopic dermatitis;Weidinger;Nat Rev Dis Primers,2018

3. Shifting paradigms in the immunology of atopic dermatitis;Hijnen;J Allergy Clin Immunol,2020